Entrust to amass most cancers care supplier MedEuropa Romania
Affidea Group, a supplier of superior diagnostics and multi-specialty outpatient clinics, has signed a binding settlement to amass MedEuropa Romania, increasing most cancers therapy providers within the nation.
The deal is awaiting approval from the Romanian Competitors Council.
Each events didn’t disclose the monetary phrases of the deal.
This strategic acquisition marks a big growth of Affidea's providers in Romania, including superior radiotherapy to its intensive portfolio.
MedEuropa, based by Telemos Capital in collaboration with regional entrepreneurs, focuses on addressing the under-supplied Romanian radiotherapy market.
The corporate gives radiotherapy along with chemotherapy and broader oncology providers.
Acquire entry to probably the most complete firm profiles available on the market, powered by GlobalData. Save hours of analysis. Acquire aggressive benefit.
Firm Profile – Free Pattern
Your obtain e mail will arrive shortly
Now we have confidence within the distinctive high quality of our firm profiles. Nevertheless, we wish you to take advantage of helpful resolution for your online business. That's why we give you a free pattern you can obtain by submitting the shape beneath.
By GlobalData
It operates 4 medical facilities in Romania, positioned in Constanta, Bucharest, Brasov and Oradea.
MedEuropa can also be planning two extra facilities in Iasi and Bacau this 12 months.
This growth joins Affidea's present diagnostic and outpatient providers in Romania to create a extra complete healthcare providing.
The acquisition will combine MedEuropa's experience in most cancers care into Affidea's Romanian operations, which at present embody 50 medical facilities in 26 cities.
Affidea Romania employs greater than 1,500 workers, together with greater than 900 physicians, and offers built-in medical providers to greater than two million sufferers yearly.
Rizoiu & Asociatii and Clifford Likelihood act as authorized advisors to Affidea Group, whereas Deloitte is the monetary advisor.
Biris Goran and Linklaters are MedEuropa's authorized advisors.
Razvan Predica, CEO of Affidea Romania and Hungary, stated: “Most cancers claims far too many lives in our communities, with round 100,000 individuals identified with an oncological illness in Romania yearly.
“This acquisition is not only about development; it's about standing shoulder to shoulder with the Nationwide Healthcare System and people affected by this brutal illness.
“We sit up for working with the nice group at MedEuropa post-closure and persevering with to ship worth to each particular person affected by most cancers, rising entry to a extra complete most cancers care pathway, from analysis to therapy and follow-up .”
